Ignite Creation Date:
2024-05-06 @ 3:50 PM
Last Modification Date:
2024-10-26 @ 1:58 PM
Study NCT ID:
NCT04774952
Status:
ACTIVE_NOT_RECRUITING
Last Update Posted:
2024-02-20
First Post:
2021-02-25
Brief Title:
Dose Escalation of RMC-5552 Monotherapy in RelapsedRefractory Solid Tumors
Sponsor:
Revolution Medicines Inc
Organization:
Revolution Medicines Inc
Conditions & Keywords Data
Conditions:
| Name |
|---|
| Solid Tumors |
Keywords:
| Name | View |
|---|---|
| 4EBP1 | View |
| PIK3CA | View |
| PTEN | View |
| TSC12 | View |
| STK11 | View |
| MTOR | View |
| MYC | View |
| MAPK | View |
| advanced solid tumor | View |
| advanced solid malignancies | View |
| melanoma | View |
| skin cancer | View |
| ovarian cancer | View |
| endometriumuterus cancer | View |
| bladder cancer | View |
| cervical cancer | View |
| Carcinoma Non-Small-Cell Lung | View |
| Neoplasms Squamous Cell | View |
| Carcinoma Squamous Cell | View |
| Esophageal Neoplasms | View |
| Carcinoma Bronchogenic | View |
| Bronchial Neoplasms | View |
| Lung Neoplasms | View |
| Respiratory Tract Neoplasms | View |
| Thoracic Neoplasms | View |
| Neoplasms by Site | View |
| Neoplasms | View |
| Lung Diseases | View |
| Respiratory Tract Diseases | View |
| Neoplasms Glandular and Epithelial | View |
| Gastrointestinal Neoplasms | View |
| Digestive System Neoplasms | View |
| Head and Neck Neoplasms | View |
| Digestive System Diseases | View |
| Esophageal Diseases | View |
| Gastrointestinal Diseases | View |